Vermilion Energy reports Q2 results on July 30 at a genuinely awkward moment — the stock is up 11% over the past month yet dipped 2.3% on Tuesday, while short sellers are quietly trimming positions ahead of a print that history suggests they may be right to respect.
The short positioning story is the most interesting structural angle this week. Short interest has fallen roughly 7% over the past week to about 3.98% of the free float — a meaningful pullback from the late-June jump, when borrowed shares spiked nearly 30% over the month. That one-month surge in shorting now appears to be partially unwinding, with bears pulling back roughly 450,000 shares from the peak level around July 7-8. Borrow conditions give shorts little reason to stay: cost to borrow has collapsed from a brief spike near 7% in late June and early July to just 0.57% today, down 74% over the month. Availability is exceptionally loose at 535% — meaning more than five shares are available to borrow for every share currently shorted — well above the 52-week low availability of 189%. This is not a squeeze setup. The lending market is wide open, and anyone wanting to establish a new short position faces minimal friction.
The Street picture is harder to read cleanly. Analyst data in the snapshot dates to August 2023 — over three years old — and cannot be used to characterise current sentiment. What the valuation data does show is that VET trades at a strikingly low EV/EBITDA of 2.85x, which has been essentially flat over the past month. The price-to-book multiple is 0.84x, down about 9% over 30 days, reflecting the stock's compressed valuation relative to its book value. A trailing P/E of 87x looks eye-catching, but the EPS momentum factor scores rank in the bottom decile over both 30-day and 90-day windows — the earnings trend has been deteriorating, not improving. The ORTEX short score has eased modestly to 41.7 this week from a recent high of 43.7 on July 17, tracking in the direction of the short interest decline. Overall factor positioning is middling: the dividend score ranks in the 69th percentile, but EPS momentum and value metrics lag the broader universe.
Institutional ownership offers some context on who has been adding. BlackRock holds the largest stake at 8.9% and added modestly through June. Dimensional Fund Advisors added nearly 1.5 million shares in the quarter through June, taking its stake to 3.2%. Mackenzie Financial, a Canadian manager with natural proximity to the name, added 1.57 million shares over the same period to reach 2.86%. On the other side, UBS Asset Management trimmed by 2.4 million shares and Arrowstreet initiated a new position of 2.26 million shares as of March — flows that collectively suggest no consensus direction among institutions.
The one data point that earns attention heading into the release is the earnings reaction history. The last time Vermilion reported — May 6 — the stock fell 12.8% on the day and was still down 7.4% five days later. That was a sharp reaction. With the stock having recovered 11% over the past month and sitting at CAD 14.62, the setup going into the July 30 print is one where the rebound in price has not been matched by improving earnings momentum, and where short sellers have been pulling back rather than piling in. Whether that short-covering reflects optimism or simply low conviction ahead of a binary event is the question the next session will answer.
See the live data behind this article on ORTEX.
Open VET on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
